Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Veracyte Inc shares valued at $564,768 were sold by EASTHAM KARIN on Nov 19 ’24. At $38.34 per share, EASTHAM KARIN sold 14,731 shares. The insider’s holdings dropped to 18,497 shares worth approximately $0.79 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, KARIN EASTHAM purchased 14,731 shares, netting a total of over 540,775 in proceeds.
Before that, Chambers Rebecca had sold 15,275 shares from its account. In a trade valued at $585,663, the Chief Financial Officer traded Veracyte Inc shares for $38.34 each. Upon closing the transaction, the insider’s holdings decreased to 15,275 shares, worth approximately $5.34 million.
As published in their initiating research note from Wolfe Research on November 15, 2024, Veracyte Inc [VCYT] has been an Outperform and the price target has been revised to $50. Analysts at UBS started covering the stock with ‘”a Buy”‘ outlook in a report released in mid October. As of October 10, 2024, Guggenheim has initiated its “Buy” rating for VCYT. Earlier on February 23, 2024, Needham resumed its rating. Their recommendation was “a Buy” for VCYT stock.
Analyzing VCYT Stock Performance
During the last five days, there has been a surge of approximately 9.41%. Over the course of the year, Veracyte Inc shares have jumped approximately 55.91%. Shares of the company reached a 52-week high of $44.16 on 11/27/24 and a 52-week low of $18.61 on 04/18/24. A 50-day SMA is recorded $35.39, while a 200-day SMA reached $26.65. Nevertheless, trading volume fell to 0.81 million shares from 0.72 million shares the previous day.
Support And Resistance Levels for Veracyte Inc (VCYT)
According to the 24-hour chart, there is a support level at 42.11, which, if violated, would cause prices to drop to 41.32. In the upper region, resistance lies at 43.92. The next price resistance is at 44.94. RSI (Relative Strength Index) is 71.59 on the 14-day chart, showing overbought technical sentiment. Moving Average Convergence Divergence (MACD) is at 3.24, which suggests the price will increase in the coming days. Percent R is at 14.45%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.
